Drug misuse and harm reduction: pharmacy's magnificent contribution, but at what cost?
1999; Wiley; Volume: 24; Issue: 3 Linguagem: Inglês
10.1046/j.1365-2710.1999.00215.x
ISSN1365-2710
Autores Tópico(s)Poisoning and overdose treatments
ResumoJournal of Clinical Pharmacy and TherapeuticsVolume 24, Issue 3 p. 165-169 Drug misuse and harm reduction: pharmacy's magnificent contribution, but at what cost? Associate Professor in Pharmacy Practice G. M. Peterson, Associate Professor in Pharmacy Practice G. M. Peterson Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, GPO Box 252–26, Hobart, Tasmania 7001, AustraliaSearch for more papers by this author Associate Professor in Pharmacy Practice G. M. Peterson, Associate Professor in Pharmacy Practice G. M. Peterson Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, GPO Box 252–26, Hobart, Tasmania 7001, AustraliaSearch for more papers by this author First published: 07 September 2005 https://doi.org/10.1046/j.1365-2710.1999.00215.xCitations: 4 Peterson G. M. E-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References Abbott FV, Fraser MI. 1998 Use and abuse of over-the-counter analgesic agents Journal of Psychiatry and Neuroscience; 23 13- 34. Bassett KE, Schunk JE, Crouch BI. 1996 Cyclizine abuse by teenagers in Utah American Journal of Emergency Medicine; 14 472- 474. Buckley NA, Whyte IM, Dawson AH, Cruickshank DA. 1994 Pheniramine – a much abused drug Medical Journal of Australia; 160 188- 192. Tinsley JA, Watkins DD. 1998 Over-the-counter stimulants: abuse and addiction Mayo Clinic Proceedings; 73 977- 982. Vestergaard L. 1993 Pulmonary edema after intravenous injection of eyedrops containing adrenaline Ugeskrift for Laeger; 155 3776- 3777. Latowsky M, Kallen E. 1997 Mainstreaming methadone maintenance treatment: the role of the family physician (editorial) Canadian Medical Association Journal; 157 395- 398. Ward J, Hall W, Mattick RP. 1999 Role of maintenance treatment in opioid dependence Lancet; 353 221- 226. Farrell M, Ward J, Mattick R, et al . 1994 Methadone maintenance treatment in opiate dependence: a review British Medical Journal; 309 997- 1001. Berbatis C. 1998 Methadone programs, harm reduction, chronic diseases and hospital pharmacists Australian Journal of Hospital Pharmacy; 28 41- 44. Muhleisen P, Lintzeris N, Koutroulis G, et al . 1998 Evaluation of methadone dispensing in community pharmacies in Victoria Australian Pharmacist; 17(8 Suppl.) 7- 12. Gruer L, Wilson P, Scott R, et al . 1997 General practitioner centred scheme for treatment of opiate dependent drug injectors in Glasgow British Medical Journal; 314 1730- 1735. Scott R, McNulty H. 1996 Community pharmacists are increasingly supervising treatments [letter] British Medical Journal; 313 272- 274. Sheridan J, Strang J, Barber N, Glanz A. 1996 Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales British Medical Journal; 313 272- 274. Winfield AJ, Kennedy EJ. 1998 Substance misuse and harm reductionIn: Winfield AJ, Richards RME, eds, 2nd edn Pharmaceutical Practice Edinburgh: Churchill Livingstone 452- 460. Stevens M. 1999 Caring is the core of the methadone program [letter] Australian Pharmacist; 18 7. Berbatis C, Sunderland VB. 1999 Injecting a sense of urgency into MMTP [letter] Australian Pharmacist; 18 8. Ali RL, Quigley AJ. 1999 Accidental drug toxicity associated with methadone maintenance treatment (editorial) Medical Journal of Australia; 170 100- 101. Byrne A, Wodak A. 1996 Census of patients receiving methadone treatment in a general practice Addiction Research; 3 341- 349. Peterson E. 1999 Methadone maintenance treatment: advocacy, information, and reform (http://methinfex .home.midspring.com). 27 January. O'brien CP. 1997 A range of research-based pharmacotherapies for addiction Science; 278 66- 70. Rosenbaum M, Washburn A, Knight K, Kelley M, Irwin J. 1996 Treatment as harm reduction, defunding as harm maximization: the case of methadone maintenance Journal of Psychoactive Drugs; 28 241- 249. Sorensen JL. 1996 Methadone treatment for opiate addicts (editorial) British Medical Journal; 313 245- 246. Wodak A. 1994 Managing illicit drug use. A practical guide Drugs; 47 446- 457. Bertschy G. 1995 Methadone maintenance treatment: an update European Archives of Psychiatry and Clinical Neuroscience; 245 114- 124. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. 1998 Effective medical treatment of opiate addiction Journal of the American Medical Association; 280 1936- 1943. Marsch LA. 1998 The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis Addiction; 93 515- 532. Stimson GV. 1995 AIDS and injecting drug use in the United Kingdom. 1987–93: the policy response and the prevention of the epidemic Social Science and Medicine; 41 699- 716. Hartel DM, Schoenbaum EE. 1998 Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City Public Health Reports; 113(Suppl. 1) 107- 115. Murray JB. 1998 Effectiveness of methadone maintenance for heroin addiction Psychological Reports; 83 295- 302. Rosenbach A, Hunot V. 1995 The introduction of a methadone prescribing programme to a drug-free treatment service: implications for harm reduction Addiction; 90 815- 821. Caplehorn JR, Drummer OH. 1999 Mortality associated with New South Wales methadone programs in 1994: lives lost and saved Medical Journal of Australia; 170 104- 109. Cairns A, Roberts Isd, Benbow EW. 1996 Characteristics of fatal methadone overdose in Manchester. 1985–94 British Medical Journal; 313 264- 265. Smith N, Temple W. 1998 Poisons information. Methadone Australian Pharmacist; 17 615- 617, 631. McCarthy JH. 1997 Treatment of opiate dependent drug misusers. More people die from methadone misuse than from heroin misuse [letter] British Medical Journal; 315 603. Calman L, Finch E, Powis B, Strang J. 1996 Only half of patients store methadone in safe place [letter] British Medical Journal; 313 1481. Garretty DJ, Wolff K, Hay AW, Raistrick D. 1997 Benzodiazepine misuse by drug addicts Annals of Clinical Biochemistry; 34 68- 73. Charnaud B, Griffiths V. 1998 Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison Drug and Alcohol Dependence; 52 79- 84. Mason BJ, Kocsis JH, Melia D, et al . 1998 Psychiatric comorbidity in methadone maintained patients Journal of Addictive Diseases; 17 75- 89. Brooner RK, Kidorf M, King VL, Stoller K. 1998 Preliminary evidence of good treatment response in antisocial drug abusers Drug and Alcohol Dependence; 49 249- 260. Ives TJ, Stults CC. 1990 Pharmacy practice in a chemical-dependency treatment center American Journal of Hospital Pharmacy; 47 1080- 1083. Australian Institute of Health and Welfare (AIHW). 1998 Pharmacy Labour Force 1995 AIHW cat. no. HWL 9. Canberra: AIHW (National Health Labour Force Series no. 12). The Pharmacy Guild of Australia. 1998 Pharmacist Supply and Demand Study Canberra: The Pharmacy Guild of Australia. The Pharmacy Guild of Australia. 1997 1997 Guild Digest. Financial Survey of Community Pharmacy Performance Canberra: The Pharmacy Guild of Australia. Peterson GM, Wu Msh, Bergin JK. 1999 Pharmacists’ attitudes towards dispensing errors: their causes and prevention Journal of Clinical Pharmacy and Therapeutics; 24, 57- 71. Bell J, Mattick R, Hay A, Chan J, Hall W. 1997 Methadone maintenance and drug-related crime Journal of Substance Abuse; 9 15- 25. MacQueen AR. 1998 GPs and methadone. Primum non nocere Australian Family Physician; 27 459- 460. Bornemann R. 1993 Advantages and disadvantages of the alternatives of private practice, public health office and clinic out-patient department as dispensaries for methadone substitution of drug users Forensic Science International; 62 57- 61. Sheridan J, Strang J, Taylor C, Barber N. 1997 HIV prevention and drug treatment services for drug misusers – a national study of community pharmacists attitudes and their involvement in service specific training Addiction; 92 1737- 1748. Sheridan J, Barber N. 1997 Drug misuse and HIV prevention – attitudes and practices of community pharmacists with respect to two London Family Health Services Authorities Addiction Research; 5 11- 21. Hall W, Darke S. 1998 Trends in opiate overdose deaths in Australia 1979–95 Drug and Alcohol Dependence; 52 71- 77. Byrne A. 1994 Methadone treatment in general practice Australian Family Physician; 23 1806- 1807. Sinclair JD. 1998 New treatment options for substance abuse from a public health viewpoint Annals of Medicine; 30 406- 411. Perneger TV, Giner F, Del Rio M, Mino A. 1998 Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments British Medical Journal; 317 13- 18. Metrebian N, Shanahan W, Wells B, Stimson GV. 1998 Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions Medical Journal of Australia; 168 596- 600. Anon.. 1998 Methadone no longer the only option Australian Pharmacist; 17 761- 762. Citing Literature Volume24, Issue3June 1999Pages 165-169 ReferencesRelatedInformation
Referência(s)